news

Our latest
Press Releases & Updates

Latest press releases

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Medical AG and Retina Consultants of America (RCA) forge a strategic partnership to revolutionize Ophthalmology data. Leveraging RetinAI's advanced AI technologies and RCA's expansive clinic network, this alliance is set to develop the largest Real World Evidence (RWE) U.S.-based database in the field.

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI Medical AG has announced a partnership with Boehringer Ingelheim to improve patient outcomes in geographic atrophy (GA). RetinAI's AI tools for identifying novel biomarkers will be used to analyze Boehringer Ingelheim's imaging datasets from clinical studies and real-world evidence to identify additional biomarkers and predictors of disease progression. This partnership aims to accelerate the development of novel treatments and enable earlier and more precise diagnosis, contributing to Boehringer Ingelheim's vision of preventing vision loss and blindness caused by retinal diseases.

RetinAI’s AI Algorithms Enrich Clinical Research and Improve Patient Care

RetinAI Medical AG has announced the acceptance of five abstracts for poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference taking place from April 23rd to 26th, 2023 in New Orleans. These studies highlight the potential of RetinAI’s Discovery platform and its certified and research use only (RUO) AI models to revolutionize healthcare decisions, improve patient care, help accelerate clinical trials, and drive better decisions for patient management.

RetinAI and Geographic Atrophy (GA) Expert Working Group partner to enable data collaboration and automated analysis of GA biomarkers for CAM using Discovery

RetinAI partnered with the Classification of Atrophy Meeting (CAM) Group in December 2022 to provide RetinAI’s Discovery® platform to the expert working group, consisting of more than 30 members, to facilitate peer-to-peer data collaboration and perform accelerated, automated biomarker analysis of real-world datasets of geographic atrophy (GA) patients. 

Latest updates

RetinAI at MICCAI'18 Labels [SEPTEMBER’18]

RetinAI participated in this year's edition of the annual International Conference on Medical Image Computing & Computer Assisted (MICCAI) in Granada, Spain, held on September 16-20.This year was the first time we sponsored the Large-Scale Annotation of Biomedical data and Expert Label Synthesis (LABELS) workshop at the event, offering a price to the winner of the competition for the best paper: 'Deep Learning Retinal Vessel Segmentation From a Single Annotated Example: An Application of Cyclic Generative Adversarial Neural Networks' by Praneeth Sadda, John A. Onofrey, and Xenophon Papademetris.

RetinAI at the NVIDIA Inception Awards [SEPTEMBER’18]

RetinAI is honoured to be one of the 10 selected projects to attend the GTC Europe Inception Awards NVIDIA, taking place in Munich between 9-11th October 2018. Hundreds of applications, 70 teams in the pitching semi-finals and only 10 teams in the final. Next step will be to compete live at the GTC to get a chance to win $100.000 and a NVIDIA DGX Workstation!

18th Euretina Congress [SEPTEMBER’18]

Our team members travelled to the European Society of Retina Specialists (EURETINA) in Vienna, 20-23 September, to present our latest products to make eye hospitals more efficient using Artificial Intelligence (AI). Stay tuned if you want to learn more about how AI is going to change the life of many eye care professionals in the near future.

AGEFI - RetinAI [JULY'18]

RetinAI is honoured to appear in the first page of AGEFI this 5th of July! Another opportunity to highlight how advanced machine learning and artificial intelligence are changing the world of ophthalmic care for the benefit of the patient and healthcare systems worldwide.

Contact us for more informations! We are happy to hear from you!